Trachtenberg Eric
Officer at KALA; GC, CCO & Secretary at Aralez Pharmaceuticals Inc.
- Sold, on record
- $63k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jan 4, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- KALAKALA BIO, Inc.Officer
- Aralez Pharmaceuticals Inc.GC, CCO & Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- KALA18,845 shares
- Aralez Pharmaceuticals Inc.11,191 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale KALAPlan not statedOct 26, 2021 2021
Sold 9,449 shares at $1.80 ($17k)
Trachtenberg Eric, Officer
Sold 7.5% of holdings ($227k position)116,666 shares leftFiling
- 2 Form 4 sale KALAPlan not statedJan 4, 2022 +70 days
Sold 2,850 shares at $1.30 ($4k)
Trachtenberg Eric, Officer
Sold 2.4% of holdings ($152k position)113,816 shares leftFiling
- 3 Form 4 sale KALAPlan not statedJun 27, 2022 +174 days
Sold 2,613 shares at $0.37 ($967)
Trachtenberg Eric, Officer
Sold 2.3% of holdings ($42k position)111,203 shares left0.9x usual sizeFiling
- 4 Form 4 sale KALAPlan not statedOct 26, 2022 +121 days
Sold 194 shares at $6.52 ($1k)
Trachtenberg Eric, Officer
Sold 8.7% of holdings ($15k position)2,030 shares left0.1x usual sizeFiling
- 5 Form 4 sale KALAPlan not statedJan 4, 2023 +70 days
Sold 60 shares at $28.55 ($2k)
Trachtenberg Eric, Officer
Sold 0.5% of holdings ($330k position)11,495 shares left0x usual sizeFiling
- 6 Form 4 sale KALANo planJan 4, 2024 +365 days
Sold 1,227 shares at $6.74 ($8k)
Trachtenberg Eric, Officer
No 10b5-1 planSold 1.8% of holdings ($467k position)68,066 shares left0.9x usual sizeFiling
- 7 Form 144 notice KALANoticeJul 16, 2024 +194 days
Filed to sell 1,281 shares ($10k)
Trachtenberg Eric, Officer
No 10b5-1 plan6.6x usual sizeFiling
- 8 Form 144 notice KALANoticeJul 17, 2024 +1 day
Filed to sell 3,917 shares ($31k)
Trachtenberg Eric, Officer
No 10b5-1 plan20.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | Jul 17, 2024 | KALA | Officer | Form 144 notice | 3,917 | $31k | Notice | SEC | |
| Jul 16, 2024 | Jul 16, 2024 | KALA | Officer | Form 144 notice | 1,281 | $10k | Notice | SEC | |
| Jan 4, 2024 | Jan 5, 2024 | KALA | Officer | Form 4 sale | 1,227 | $8k | 1.8% | No plan | SEC |
| Jan 4, 2023 | Jan 6, 2023 | KALA | Officer | Form 4 sale | 60 | $2k | 0.5% | Plan not stated | SEC |
| Oct 26, 2022 | Oct 28, 2022 | KALA | Officer | Form 4 sale | 194 | $1k | 8.7% | Plan not stated | SEC |
| Jun 27, 2022 | Jun 29, 2022 | KALA | Officer | Form 4 sale | 2,613 | $967 | 2.3% | Plan not stated | SEC |
| Jan 4, 2022 | Jan 5, 2022 | KALA | Officer | Form 4 sale | 2,850 | $4k | 2.4% | Plan not stated | SEC |
| Oct 26, 2021 | Oct 28, 2021 | KALA | Officer | Form 4 sale | 9,449 | $17k | 7.5% | Plan not stated | SEC |
| Jun 28, 2021 | Jun 29, 2021 | KALA | Officer | Form 4 sale | 2,452 | $14k | 1.9% | Plan not stated | SEC |
| Mar 19, 2018 | Mar 21, 2018 | Aralez Pharmaceuticals Inc. | GC, CCO & Secretary | Form 4 sale | 3,471 | $6k | 1.7% | Plan not stated | SEC |
| Jun 23, 2017 | Jun 23, 2017 | Aralez Pharmaceuticals Inc. | GC, CCO & Secretary | Form 4 sale | 7,720 | $10k | 3.7% | Plan not stated | SEC |